US HB1285 | 2013-2014 | 113th Congress
Status
Spectrum: Bipartisan Bill
Status: Introduced on March 20 2013 - 25% progression, died in committee
Action: 2013-04-15 - Referred to the Subcommittee on Crime, Terrorism, Homeland Security, And Investigations.
Pending: House Subcommittee on Crime, Terrorism, Homeland Security, And Investigations Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on March 20 2013 - 25% progression, died in committee
Action: 2013-04-15 - Referred to the Subcommittee on Crime, Terrorism, Homeland Security, And Investigations.
Pending: House Subcommittee on Crime, Terrorism, Homeland Security, And Investigations Committee
Text: Latest bill text (Introduced) [PDF]
Summary
Amends the Controlled Substances Act to remove dihydrocodeinone (hydrocodone) from classification as a schedule III controlled substance. Directs the Attorney General to immediately allow manufacturers and distributors to store hydrocodone compound products in accordance with the physical security requirements for schedule III, IV, and V controlled substances for three years beginning on the date enactment of this Act. Requires the Comptroller General to submit a report on the reclassification of hydrocodone products under this Act, including: (1) an assessment of the degree to which the reclassification of such products under this Act impacts the ability of patients with legitimate medical needs, particularly those in rural areas and nursing home facilities, to access adequate pain management; and (2) recommendations necessary to address any issues relating to patient access to adequate pain management.
Title
To amend the Controlled Substances Act to make any substance containing hydrocodone a schedule II drug.
Sponsors
History
| Date | Chamber | Action |
|---|---|---|
| 2013-04-15 | House | Referred to the Subcommittee on Crime, Terrorism, Homeland Security, And Investigations. |
| 2013-03-22 | House | Referred to the Subcommittee on Health. |
| 2013-03-20 | House | Referred to House Judiciary |
| 2013-03-20 | House | Referred to House Energy and Commerce |
| 2013-03-20 | House | Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. |
Same As/Similar To
SB621 (Related) 2013-03-20 - Read twice and referred to the Committee on the Judiciary.
Subjects
Crime and law enforcement
Drug trafficking and controlled substances
Health care coverage and access
Long-term, rehabilitative, and terminal care
Prescription drugs
Rural conditions and development
Drug trafficking and controlled substances
Health care coverage and access
Long-term, rehabilitative, and terminal care
Prescription drugs
Rural conditions and development
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/113th-congress/house-bill/1285/all-info |
| Text | https://www.congress.gov/113/bills/hr1285/BILLS-113hr1285ih.pdf |
